Bradley Foster & Sargent Inc Fate Therapeutics Inc Transaction History

Bradley Foster & Sargent Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Mar 11, 2022	SELL	$47.84 - $64.34 $222,790 - $299,631	-4,657 Closed	0 $0
Q2 2021 Aug 19, 2021	SELL	$67.25 - $92.52 $251,111 - $345,469	-3,734 Reduced 44.5%	4,657 $404,000
Q1 2021 Apr 26, 2021	SELL	$72.16 - $117.4 $1,226 - $1,995	-17 Reduced 0.2%	8,391 $692,000
Q4 2020 Feb 11, 2021	SELL	$38.09 - $100.95 $23,311 - $61,781	-612 Reduced 6.78%	8,408 $765,000
Q3 2020 Oct 26, 2020	BUY	$30.41 - $40.5 $274,298 - $365,310	9,020 New	9,020 $361,000

175

115M

53.7K

Ticker FATE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,000,304
Market Cap $196M
Description
Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell...

Get notified when there are updates to the investment portfolio of Bradley Foster & Sargent Inc, based on Form 13F filings with the SEC.

Stay updated on Bradley Foster & Sargent Inc with notifications on news.